Ethan Weiss is a Cardiology physician affiliated with University of California, San Francisco. OpenAlex indexes 83 publications with 4,447 citations (h-index 25); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Parnassus Ave
San Francisco, CA 941173617
Telephone
415-476-5405Registry record last updated 11 Sept 2025.
Clinical trials
- Study of Time-restricted Eating on Weight Loss.
Sponsor: University of California, San Francisco
- Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.8%Statin31%Atorvastatin Calcium71%Rosuvastatin Calcium29%Part D<11 patientsPCSK9 Inhibitor14%Repatha Sureclick100%Part D≥12 patients+ 6 more classes in this area
Blood & clotting
11.2%Factor Xa inhibitor11.2%Eliquis100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2004–2022 per NIH RePORTER. The latest:
- Can neural network instability in schizophrenia be improved with a very low carbohydrate ketogenic diet?
Northern California Institute/res/edu
FY2022$59,660R21MH127498 - Can neural network instability in schizophrenia be improved with a very low carbohydrate ketogenic diet?
Northern California Institute/res/edu
FY2021$229,950R21MH127498 - Growth hormone signaling and lipid metabolism in fatty liver disease
University of California, San Francisco
FY2015$336,038R01DK091276
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”